Agios Pharmaceuticals | Liquidités



Cash And Equivalent Changement Date
AbbVie USD 5.52B 1.73B 2024-12
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 183.75M 33.62M 2025-04
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Agios Pharmaceuticals Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.